BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff

With 2022 in the books, many in the biopharma industry are looking back at the year that's passed and noticing trends that may help predict what's to come in 2023.

2022 saw myriad ups and downs in terms of the economy, and as it ebbed and flowed, so too did the job market.

As the COVID-19 pandemic waned, rumors of a potential recession began to circulate, causing biotechs and pharma giants alike to implement cost-reduction strategies. This included industry leaders like Novartis, GSK, Bristol Myers Squibb, AbbVie and more.